• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Women's perspectives of the fetal fibronectin testing process: a qualitative descriptive study.女性对胎儿纤连蛋白检测过程的看法:一项定性描述性研究。
BMC Pregnancy Childbirth. 2014 Jun 4;14:190. doi: 10.1186/1471-2393-14-190.
2
Preterm labour decision-making and experiences of care for women and clinicians (QUIDS Qualitative): A qualitative exploration.早产劳动力决策和妇女及临床医生护理体验(QUIDS 定性):定性探索。
Sex Reprod Healthc. 2019 Oct;21:95-101. doi: 10.1016/j.srhc.2019.06.005. Epub 2019 Jun 27.
3
Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.评估定量胎儿纤连蛋白检测和PAMG-1检测对有早产迹象和症状患者自发性早产的预测价值。
J Matern Fetal Neonatal Med. 2019 Dec;32(23):3909-3914. doi: 10.1080/14767058.2018.1476485. Epub 2018 May 28.
4
The Biomarkers for Preterm Birth Study-A prospective observational study comparing the impact of vaginal biomarkers on clinical practice when used in women with symptoms of preterm labor.早产生物标志物研究-一项前瞻性观察研究,比较了在有早产症状的妇女中使用阴道生物标志物对临床实践的影响。
Acta Obstet Gynecol Scand. 2020 Feb;99(2):249-258. doi: 10.1111/aogs.13729. Epub 2019 Oct 8.
5
New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.有症状孕妇自发性早产预测的新型生物标志物:与胎儿纤连蛋白的比较
BJOG. 2015 Feb;122(3):370-9. doi: 10.1111/1471-0528.12993. Epub 2014 Jul 24.
6
Use of fetal fibronectin testing in women transferred for threatened preterm labour in remote far north Queensland.在昆士兰极北偏远地区因先兆早产而转诊的女性中使用胎儿纤连蛋白检测。
Aust N Z J Obstet Gynaecol. 2019 Jun;59(3):403-407. doi: 10.1111/ajo.12878. Epub 2018 Sep 3.
7
Preterm delivery: predictive value of cervico-vaginal fetal fibronectin.
Clin Exp Obstet Gynecol. 1999;26(3-4):187-9.
8
Fetal fibronectin and preterm birth.
Acta Obstet Gynecol Scand. 1993 Oct;72(7):507-8. doi: 10.3109/00016349309058152.
9
Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms.
Am J Obstet Gynecol. 2003 Jun;188(6):1588-93; discussion 1593-5. doi: 10.1067/mob.2003.390.
10
Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth.宫颈阴道分泌物中的胎儿纤连蛋白作为早产的预测指标
Br J Obstet Gynaecol. 1996 Jul;103(7):648-53. doi: 10.1111/j.1471-0528.1996.tb09832.x.

引用本文的文献

1
Vasa Previa and the Role of Fetal Fibronectin and Cervical Length Surveillance: A Review.前置血管以及胎儿纤连蛋白和宫颈长度监测的作用:一篇综述
Diagnostics (Basel). 2024 May 15;14(10):1016. doi: 10.3390/diagnostics14101016.
2
The acceptability of cervical electrical impedance spectroscopy within a multi-modal preterm birth screening package: a mixed methods study.多模态早产筛查方案中宫颈电阻抗频谱分析的可接受性:一项混合方法研究。
BMC Pregnancy Childbirth. 2022 Dec 22;22(1):959. doi: 10.1186/s12884-022-05202-z.
3
Fetal Fibronectin as a Predictor of Preterm Delivery: A Nigerian Cohort Study.胎儿纤维连接蛋白作为预测早产的指标:一项尼日利亚队列研究。
Biomed Res Int. 2022 Sep 15;2022:2442338. doi: 10.1155/2022/2442338. eCollection 2022.
4
Characteristics of Qualitative Descriptive Studies: A Systematic Review.定性描述性研究的特征:一项系统评价
Res Nurs Health. 2017 Feb;40(1):23-42. doi: 10.1002/nur.21768. Epub 2016 Sep 30.
5
Consumers attitudes and beliefs towards the receipt of antenatal corticosteroids and use of clinical practice guidelines.消费者对接受产前皮质类固醇及使用临床实践指南的态度和信念。
BMC Pregnancy Childbirth. 2016 Sep 5;16(1):259. doi: 10.1186/s12884-016-1043-4.

本文引用的文献

1
The influence of medical testing on patients' health: an overview from the gynecologists' perspective.医学检测对患者健康的影响:从妇科医生的角度进行概述。
BMC Med Inform Decis Mak. 2013 Oct 10;13:117. doi: 10.1186/1472-6947-13-117.
2
Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study.内容分析和主题分析:对开展定性描述性研究的启示。
Nurs Health Sci. 2013 Sep;15(3):398-405. doi: 10.1111/nhs.12048. Epub 2013 Mar 11.
3
Fetal fibronectin testing in Ontario: successful government-sector collaboration to achieve high-quality and sustainable system change.
Healthc Q. 2011;14 Spec No 3:90-4. doi: 10.12927/hcq.2011.22583.
4
The reassuring value of diagnostic tests: a systematic review.诊断测试的可靠性价值:系统评价。
Patient Educ Couns. 2012 Jan;86(1):3-8. doi: 10.1016/j.pec.2011.02.003. Epub 2011 Mar 6.
5
Women's views of high risk pregnancy under threat of preterm birth.女性对早产威胁下高危妊娠的看法。
Sex Reprod Healthc. 2010 Aug;1(3):79-84. doi: 10.1016/j.srhc.2010.05.001. Epub 2010 May 22.
6
Waiting is the hardest part: anticipating medical test results affects processing and recall of important information.等待是最困难的部分:预测医疗检测结果会影响对重要信息的处理和回忆。
Soc Sci Med. 2010 Jul;71(2):421-428. doi: 10.1016/j.socscimed.2010.04.012.
7
Preterm labor.早产
Am Fam Physician. 2010 Feb 15;81(4):477-84.
8
What's in a name? Qualitative description revisited.名称的含义是什么?重新审视定性描述。
Res Nurs Health. 2010 Feb;33(1):77-84. doi: 10.1002/nur.20362.
9
Additional patient outcomes and pathways in evaluations of testing.检测评估中的附加患者结局和途径。
Med Decis Making. 2009 Sep-Oct;29(5):E30-8. doi: 10.1177/0272989X09347013. Epub 2009 Sep 2.
10
Epidemiology and causes of preterm birth.早产的流行病学及病因
Lancet. 2008 Jan 5;371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4.

女性对胎儿纤连蛋白检测过程的看法:一项定性描述性研究。

Women's perspectives of the fetal fibronectin testing process: a qualitative descriptive study.

作者信息

Peterson Wendy E, Sprague Ann E, Reszel Jessica, Walker Mark, Fell Deshayne B, Perkins Sherry L, Dunn Sandra I, Johnson Moya

机构信息

School of Nursing, Faculty of Health Sciences, University of Ottawa, 451 Smyth Road, Room 1118 F, Ottawa, Ontario K1H 8M5, Canada.

出版信息

BMC Pregnancy Childbirth. 2014 Jun 4;14:190. doi: 10.1186/1471-2393-14-190.

DOI:10.1186/1471-2393-14-190
PMID:24894630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4055372/
Abstract

BACKGROUND

In 2009 the Ontario Ministry of Health and Long Term Care funded the implementation of province-wide fetal fibronectin testing in Ontario hospitals. This paper reports results from the provincial evaluation that sought to describe the experience of fetal fibronectin testing from the perspective of women with symptoms of preterm labour.

METHODS

A descriptive qualitative design was used, employing semi-structured telephone and face-to-face interviews with women who had fetal fibronectin testing.

RESULTS

Five hospitals participated in recruiting women for the study and 17 women were interviewed. Women described their experiences of fetal fibronectin testing as an emotional process that moves from expecting, to feeling, to hoping for reassurance; and then to re-defining what is required to feel reassured. Women described feeling anxious while waiting for fetal fibronectin results. When test results were negative, women described feeling a sense of relief that their symptoms would not likely lead to an imminent preterm birth. Women with positive results expressed feeling reassured by the care decisions and quick action taken by the health care team.

CONCLUSION

Fetal fibronectin testing was acceptable and beneficial to these women with symptoms of preterm labour. Implications for practice and future research are suggested.

摘要

背景

2009年,安大略省卫生与长期护理部资助在安大略省各医院开展全省范围的胎儿纤连蛋白检测。本文报告了该省评估的结果,该评估旨在从有早产症状的女性角度描述胎儿纤连蛋白检测的经历。

方法

采用描述性定性设计,对接受胎儿纤连蛋白检测的女性进行半结构化电话访谈和面对面访谈。

结果

五家医院参与招募女性参与研究,共访谈了17名女性。女性将她们的胎儿纤连蛋白检测经历描述为一个情感过程,从期待,到感受,再到希望得到安心;然后重新定义获得安心所需的条件。女性表示在等待胎儿纤连蛋白检测结果时感到焦虑。检测结果为阴性时,女性表示松了一口气,因为她们的症状不太可能导致即将早产。检测结果为阳性的女性表示,医护团队的护理决策和迅速行动让她们感到安心。

结论

胎儿纤连蛋白检测对这些有早产症状的女性来说是可以接受且有益的。文中还提出了对实践和未来研究的启示。